We discovered our drug has a serious side effect that affects maybe two percent of patients and the regulatory team is debating whether to report it immediately or wait for more data.
More people experience this than they realize.
Patient safety and business interests operate on different timelines and create genuine ethical dilemmas.
“Where Are You with Science — Biotech & Pharmaceutical R&D?”
Peri can explain why this happens, help you decide if this is the right situation for you, and point toward the right journey or coach.
If this sounds familiar, the Library can help you find the bigger picture.